FDA Inspection 1111804 — Joshua (NMI) Wolf
The FDA completed an inspection of Joshua (NMI) Wolf on November 21, 2019 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 21, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Memphis, TN (United States)
Additional Details
Clinical Investigator (CI)